EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieFallberichtKlinische StudieOpen Access · CC BY-NC 3.0

Atorvastatin for the Prevention of Cisplatin-Induced Ototoxicity: A Randomized Controlled Trial

Noha H Helmy, Eman Mohamed Sadek, Dalia Fahim Mohammed Fahim, Nada Hussein Sholkamy, Sumaiah J Alarfaj iD, Fatma M Mady

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-15

DOI: 10.2147/dddt.s649303 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Noha H Helmy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, Minia University, Minia, Egypt. Hauptthemen laut MEDLINE: Cisplatin, Atorvastatin, Ototoxicity, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAtorvastatinOtotoxicityAntineoplastic AgentsHearing LossHumansMaleFemaleMiddle AgedAdult

Stichwörter der Autor:innen

CIOSSQ12 questionnaireatorvastatinaudiogramcisplatin-induced ototoxicityhearing loss

Substanzen

CisplatinAtorvastatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Faculty of Pharmacy, Minia University, Minia, Egypt.
  • ENT Department (Audio-Vestibular Medicine), Faculty of Medicine, Minia University, Minia, Egypt.
  • Department of Clinical Oncology, Faculty of Medicine, Minia University, Minia, Egypt.
  • Department of Clinical Oncology, Minia Oncology Institute, Minia, Egypt.
  • Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt.

ORCID-Profile: Sumaiah J Alarfaj

Zitieren

APA

Helmy, N. H., Sadek, E. M., Fahim, D. F. M., Sholkamy, N. H., Alarfaj, S. J., & Mady, F. M. (2026). Atorvastatin for the Prevention of Cisplatin-Induced Ototoxicity: A Randomized Controlled Trial. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s649303

Vancouver

Helmy NH, Sadek EM, Fahim DFM, Sholkamy NH, Alarfaj SJ, Mady FM. Atorvastatin for the Prevention of Cisplatin-Induced Ototoxicity: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s649303

BibTeX
@article{Helmy2026,
  author = {Helmy, Noha H and Sadek, Eman Mohamed and Fahim, Dalia Fahim Mohammed and Sholkamy, Nada Hussein and Alarfaj, Sumaiah J and Mady, Fatma M},
  title = {Atorvastatin for the Prevention of Cisplatin-Induced Ototoxicity: A Randomized Controlled Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--15},
  doi = {10.2147/dddt.s649303}
}
Kostenlos starten →